Previous Close | 10.86 |
Open | 10.86 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 250.00 |
Expire Date | 2024-11-15 |
Day's Range | 10.86 - 10.86 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
BD's robust product portfolio and a few strategic deals raise optimism about the stock. However, stiff competition and macroeconomic volatility are concerns.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has reached an agreement to resolve the vast majority of its existing hernia litigation.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.